EGP-Net: a lung nodule segmentation network integrating edge guidance and pyramidal multi-scale contextual attention mechanisms

• by Xiangsuo Fan, Lihong Deng, Jiachen Hou, Tao Li, Zhougui Ling, Shuping Li

• July 2, 2026

ASCO26: Michael Hassett, MD, MPH, eSyM

Dr. Michael Hassett of Dana-Farber Cancer Institute shared new findings showing deployment of eSyM, an ePRO-based, EHR-integrated symptom management program, was associated with statistically significant and potentially meaningful improvements in overall survival. Strategies to improve adoption of ePRO-based symptom management may be warranted.

• July 1, 2026

• 1 min

ASCO26: Sara Tolaney, MD, MPH, ASCENT-04

Dana-Farber Cancer Institute's Dr. Sara Tolaney presented a subgroup analysis of the ASCENT-04 study based on biomarkers. Across all subgroups, patients who received sacituzumab govitecan plus pembro as first-line therapy had longer progression-free survival compared to standard therapy.

• July 1, 2026

• 1 min

A novel bimanual endoluminal robotic platform compatible with standard gastroscopes for endoscopic submucosal dissection: preclinical feasibility and ergonomic evaluation

• by Yung Lee, Ji Seok Park, Stephen Firkins, Sera Satoi, Vikash Fnu, Kyungran Justina Cho, Amit Bhatt

• July 1, 2026